Filter
869
Text search:
isoniazid
Featured
110
251
Language
Document type
648
101
55
29
10
10
9
4
3
Countries / Regions
47
35
30
30
26
26
26
23
20
19
18
17
14
13
12
11
10
9
9
9
8
8
7
7
7
7
6
6
6
5
5
4
4
4
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
345
92
18
16
15
10
7
Toolboxes
404
96
30
17
13
13
12
9
8
4
2
2
2
1
Tuberculosis MDR-TB & XDR-TB The 2008 Report
8–18 December 2015
Medicina (Kaunas) 2013;49(7):335-40
17–24 November 2015
4–15 February 2013
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
Epidemiologisches Bulletin; 22. August 2016 / Nr. 33 ;DOI 10.17886/EpiBull-2016-050
Western Pac Surveill Response J. 2014 Oct-Dec; 5(4): 34–46.
Published online 2014 Dec 18. doi: [10.5365/WPSAR.2014.5.4.007]
15. Euro Surveill. 2017;22(47):pii=17-00103
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
